Product Name: MEM-48 (IgG1)
Background: CD18, integrin beta2 subunit, forms heterodimers with four types of CD11 molecule to constitute leukocyte (beta2) integrins: alphaLbeta2 (CD11a/CD18, LFA-1), alphaMbeta2 (CD11b/CD18, Mac-1, CR3), alphaXbeta2 (CD11c/CD18) and alphaDbeta2 (CD11d/CD18). In m
Specificity: The antibody MEM-48 recognizes an epitope involving residues 534-546 in cysteine-rich repeat 3 of the CD18 antigen (integrin beta2 subunit; beta2 integrin). CD18 is a 90-95 kDa type I transmembrane protein expressed on all leukocytes.Regulatory Status RUO
Immunogen: Leukocytes of a patient suffering from a LGL-type leukemia.
CAS NO: 849479-74-9
Product: Vapreotide (acetate)
Species Reactivity: Human
Negative Species: Canine (Dog)
Applications: Flow CytometryRecommended dilution: 2 μg/mlImmunoprecipitationWestern BlottingRecommended dilution: 2 μg/mlPositive control: Kg-1a human leukemia cell lysateSample preparation: buffer with laurylmaltoside, 2 x non-reducing SDSApplication note: N
PubMed ID:http://aac.asm.org/content/49/7/3056.abstract
Product Name: MEM-48 (IgG1)
Background: CD18, integrin beta2 subunit, forms heterodimers with four types of CD11 molecule to constitute leukocyte (beta2) integrins: alphaLbeta2 (CD11a/CD18, LFA-1), alphaMbeta2 (CD11b/CD18, Mac-1, CR3), alphaXbeta2 (CD11c/CD18) and alphaDbeta2 (CD11d/CD18). In m
Specificity: The antibody MEM-48 recognizes an epitope involving residues 534-546 in cysteine-rich repeat 3 of the CD18 antigen (integrin beta2 subunit; beta2 integrin). CD18 is a 90-95 kDa type I transmembrane protein expressed on all leukocytes.Regulatory Status RUO
Immunogen: Leukocytes of a patient suffering from a LGL-type leukemia.
CAS NO: 849479-74-9
Product: Vapreotide (acetate)
Species Reactivity: Human
Negative Species: Canine (Dog)
Applications: Flow CytometryRecommended dilution: 2 μg/mlImmunoprecipitationWestern BlottingRecommended dilution: 2 μg/mlPositive control: Kg-1a human leukemia cell lysateSample preparation: buffer with laurylmaltoside, 2 x non-reducing SDSApplication note: N
PubMed ID:http://aac.asm.org/content/49/7/3056.abstract
Product Name: MEM-48 (IgG1)
Background: CD18, integrin beta2 subunit, forms heterodimers with four types of CD11 molecule to constitute leukocyte (beta2) integrins: alphaLbeta2 (CD11a/CD18, LFA-1), alphaMbeta2 (CD11b/CD18, Mac-1, CR3), alphaXbeta2 (CD11c/CD18) and alphaDbeta2 (CD11d/CD18). In m
Specificity: The antibody MEM-48 recognizes an epitope involving residues 534-546 in cysteine-rich repeat 3 of the CD18 antigen (integrin beta2 subunit; beta2 integrin). CD18 is a 90-95 kDa type I transmembrane protein expressed on all leukocytes.Regulatory Status RUO
Immunogen: Leukocytes of a patient suffering from a LGL-type leukemia.
CAS NO: 849479-74-9
Product: Vapreotide (acetate)
Species Reactivity: Human
Negative Species: Canine (Dog)
Applications: Flow CytometryRecommended dilution: 2 μg/mlImmunoprecipitationWestern BlottingRecommended dilution: 2 μg/mlPositive control: Kg-1a human leukemia cell lysateSample preparation: buffer with laurylmaltoside, 2 x non-reducing SDSApplication note: N
PubMed ID:http://aac.asm.org/content/49/7/3056.abstract
Product Name: MEM-48 (IgG1)
Background: CD18, integrin beta2 subunit, forms heterodimers with four types of CD11 molecule to constitute leukocyte (beta2) integrins: alphaLbeta2 (CD11a/CD18, LFA-1), alphaMbeta2 (CD11b/CD18, Mac-1, CR3), alphaXbeta2 (CD11c/CD18) and alphaDbeta2 (CD11d/CD18). In m
Specificity: The antibody MEM-48 recognizes an epitope involving residues 534-546 in cysteine-rich repeat 3 of the CD18 antigen (integrin beta2 subunit; beta2 integrin). CD18 is a 90-95 kDa type I transmembrane protein expressed on all leukocytes.Regulatory Status RUO
Immunogen: Leukocytes of a patient suffering from a LGL-type leukemia.
CAS NO: 849479-74-9
Product: Vapreotide (acetate)
Species Reactivity: Human
Negative Species: Canine (Dog)
Applications: Flow CytometryRecommended dilution: 2 μg/mlImmunoprecipitationWestern BlottingRecommended dilution: 2 μg/mlPositive control: Kg-1a human leukemia cell lysateSample preparation: buffer with laurylmaltoside, 2 x non-reducing SDSApplication note: N
PubMed ID:http://aac.asm.org/content/49/7/3056.abstract
Product Name: MEM-48 (IgG1)
Background: CD18, integrin beta2 subunit, forms heterodimers with four types of CD11 molecule to constitute leukocyte (beta2) integrins: alphaLbeta2 (CD11a/CD18, LFA-1), alphaMbeta2 (CD11b/CD18, Mac-1, CR3), alphaXbeta2 (CD11c/CD18) and alphaDbeta2 (CD11d/CD18). In m
Specificity: The antibody MEM-48 recognizes an epitope involving residues 534-546 in cysteine-rich repeat 3 of the CD18 antigen (integrin beta2 subunit; beta2 integrin). CD18 is a 90-95 kDa type I transmembrane protein expressed on all leukocytes.Regulatory Status RUO
Immunogen: Leukocytes of a patient suffering from a LGL-type leukemia.
CAS NO: 849479-74-9
Product: Vapreotide (acetate)
Species Reactivity: Human
Negative Species: Canine (Dog)
Applications: Flow CytometryRecommended dilution: 2 μg/mlImmunoprecipitationWestern BlottingRecommended dilution: 2 μg/mlPositive control: Kg-1a human leukemia cell lysateSample preparation: buffer with laurylmaltoside, 2 x non-reducing SDSApplication note: N
PubMed ID:http://aac.asm.org/content/49/7/3056.abstract
Product Name: MEM-48 (IgG1)
Background: CD18, integrin beta2 subunit, forms heterodimers with four types of CD11 molecule to constitute leukocyte (beta2) integrins: alphaLbeta2 (CD11a/CD18, LFA-1), alphaMbeta2 (CD11b/CD18, Mac-1, CR3), alphaXbeta2 (CD11c/CD18) and alphaDbeta2 (CD11d/CD18). In m
Specificity: The antibody MEM-48 recognizes an epitope involving residues 534-546 in cysteine-rich repeat 3 of the CD18 antigen (integrin beta2 subunit; beta2 integrin). CD18 is a 90-95 kDa type I transmembrane protein expressed on all leukocytes.Regulatory Status RUO
Immunogen: Leukocytes of a patient suffering from a LGL-type leukemia.
CAS NO: 718635-93-9
Product: Tetrabenazine (Racemate)
Species Reactivity: Human
Negative Species: Canine (Dog)
Applications: Flow CytometryRecommended dilution: 2 μg/mlImmunoprecipitationWestern BlottingRecommended dilution: 2 μg/mlPositive control: Kg-1a human leukemia cell lysateSample preparation: buffer with laurylmaltoside, 2 x non-reducing SDSApplication note: N
PubMed ID:http://aac.asm.org/content/50/5/1887.abstract